These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 21228059)

  • 1. Frequency and risk factors of gout flares in a large population-based cohort of incident gout.
    Rothenbacher D; Primatesta P; Ferreira A; Cea-Soriano L; Rodríguez LA
    Rheumatology (Oxford); 2011 May; 50(5):973-81. PubMed ID: 21228059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population.
    Primatesta P; Plana E; Rothenbacher D
    BMC Musculoskelet Disord; 2011 May; 12():103. PubMed ID: 21599917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cohort study investigating gout flares and management in UK general practice.
    Finnikin S; Mallen CD; Roddy E
    BMC Prim Care; 2023 Nov; 24(1):246. PubMed ID: 37993770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gout, flares, and allopurinol use: a population-based study.
    Proudman C; Lester SE; Gonzalez-Chica DA; Gill TK; Dalbeth N; Hill CL
    Arthritis Res Ther; 2019 May; 21(1):132. PubMed ID: 31151457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.
    Bakris GL; Doghramji PP; Keenan RT; Silber SH
    Am J Med; 2014 Jan; 127(1):S1. PubMed ID: 24268074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allopurinol adherence among patients with gout: an Italian general practice database study.
    Mantarro S; Capogrosso-Sansone A; Tuccori M; Blandizzi C; Montagnani S; Convertino I; Antonioli L; Fornai M; Cricelli I; Pecchioli S; Cricelli C; Lapi F
    Int J Clin Pract; 2015 Jul; 69(7):757-65. PubMed ID: 25683693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with recurrent hospital admissions for gout: a case-control study.
    Hutton I; Gamble G; Gow P; Dalbeth N
    J Clin Rheumatol; 2009 Sep; 15(6):271-4. PubMed ID: 19734730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep Apnea and the Risk of Incident Gout: A Population-Based, Body Mass Index-Matched Cohort Study.
    Zhang Y; Peloquin CE; Dubreuil M; Roddy E; Lu N; Neogi T; Choi HK
    Arthritis Rheumatol; 2015 Dec; 67(12):3298-302. PubMed ID: 26477891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of diuretics and risk of incident gout: a population-based case-control study.
    Bruderer S; Bodmer M; Jick SS; Meier CR
    Arthritis Rheumatol; 2014 Jan; 66(1):185-96. PubMed ID: 24449584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onset of comorbidities and flare patterns within pre-existing morbidity clusters in people with gout: 5-year primary care cohort study.
    Bajpai R; Muller S; Mallen C; Watson L; Richette P; Hider SL; Roddy E
    Rheumatology (Oxford); 2021 Dec; 61(1):407-412. PubMed ID: 33744931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient and clinical characteristics associated with gout flares in an integrated healthcare system.
    Rashid N; Levy GD; Wu YL; Zheng C; Koblick R; Cheetham TC
    Rheumatol Int; 2015 Nov; 35(11):1799-807. PubMed ID: 25991397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum urate levels and gout flares: analysis from managed care data.
    Sarawate CA; Patel PA; Schumacher HR; Yang W; Brewer KK; Bakst AW
    J Clin Rheumatol; 2006 Apr; 12(2):61-5. PubMed ID: 16601538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the Presentation of Incident Gout and the Risk of Subsequent Flares: A Population-based Study over 20 Years.
    Elfishawi MM; Zleik N; Kvrgic Z; Michet CJ; Crowson CS; Matteson EL; Bongartz T
    J Rheumatol; 2020 Apr; 47(4):613-618. PubMed ID: 31308206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gout and the risk of Alzheimer's disease: a population-based, BMI-matched cohort study.
    Lu N; Dubreuil M; Zhang Y; Neogi T; Rai SK; Ascherio A; Hernán MA; Choi HK
    Ann Rheum Dis; 2016 Mar; 75(3):547-51. PubMed ID: 25739830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of gout with incident giant cell arteritis in older adults.
    Singh JA; Cleveland JD
    Joint Bone Spine; 2019 Mar; 86(2):219-224. PubMed ID: 29885976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary epidemiology of gout in the UK general population.
    Cea Soriano L; Rothenbacher D; Choi HK; García Rodríguez LA
    Arthritis Res Ther; 2011 Mar; 13(2):R39. PubMed ID: 21371293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Septic arthritis in gout patients: a population-based cohort study.
    Lim SY; Lu N; Choi HK
    Rheumatology (Oxford); 2015 Nov; 54(11):2095-9. PubMed ID: 26170377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice Population.
    Robinson PC; Taylor WJ; Dalbeth N
    J Rheumatol; 2015 Sep; 42(9):1702-7. PubMed ID: 26233513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allopurinol initiation and all-cause mortality in the general population.
    Dubreuil M; Zhu Y; Zhang Y; Seeger JD; Lu N; Rho YH; Choi HK
    Ann Rheum Dis; 2015 Jul; 74(7):1368-72. PubMed ID: 24665118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of adherence and persistence with allopurinol therapy among gout patients in Israel.
    Zandman-Goddard G; Amital H; Shamrayevsky N; Raz R; Shalev V; Chodick G
    Rheumatology (Oxford); 2013 Jun; 52(6):1126-31. PubMed ID: 23392592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.